| scholarly article | Q13442814 |
| P2093 | author name string | Mukul R Jain | |
| Savan Patel | |||
| Aviseka Acharya | |||
| Hitesh M Soni | |||
| Praful P Patel | |||
| Akshyaya C Rath | |||
| Harshkant D Trivedi | |||
| P2860 | cites work | Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis | Q58007003 |
| Urinary tumor necrosis factor levels in primary glomerulopathies | Q72436535 | ||
| Renoprotective effects of telmisartan in the 5/6 nephrectomised rats | Q80805610 | ||
| Aliskiren-associated acute kidney injury in a patient with pre-existing chronic kidney disease and dilated cardiomyopathy | Q82732434 | ||
| Direct renin inhibition in a rat model of chronic allograft injury | Q85008929 | ||
| Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril | Q28215905 | ||
| Kinin B1 Receptor Enhances the Oxidative Stress in a Rat Model of Insulin Resistance: Outcome in Hypertension, Allodynia and Metabolic Complications | Q28749408 | ||
| Prevalence of chronic kidney disease in the United States | Q29614191 | ||
| Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists | Q35789813 | ||
| Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications | Q36033383 | ||
| Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection | Q37290939 | ||
| A rapid urine test for early detection of kidney injury. | Q37331901 | ||
| Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium | Q37348057 | ||
| Plasma levels of TNF and IL-6 following induction of acute pancreatitis and pentoxifylline treatment in rats. | Q41136875 | ||
| Role of growth hormone in the development of experimental renal scarring | Q44733999 | ||
| Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition | Q44807372 | ||
| Role of TNF-α in renal damage in mice showing hepatic steatosis induced by high fat diet | Q44855451 | ||
| Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats | Q44942922 | ||
| Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure | Q44948985 | ||
| Aliskiren-associated acute renal failure with hyperkalemia. | Q46090773 | ||
| Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy | Q46352491 | ||
| Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats | Q46587391 | ||
| The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes | Q46840286 | ||
| Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart. | Q51441141 | ||
| Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial. | Q51493437 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 80-85 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Indian Journal of Pharmacology | Q15710016 |
| P1476 | title | Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure | |
| P478 | volume | 47 |
Search more.